Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19323
Title: Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair.
Austin Authors: Teh, Jiasian ;Kinnear, Ned J;Douglass-Molloy, Hannah;Hennessey, Derek Barry
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Issue Date: 25-Jan-2017
Date: 2017
Publication information: BMJ Case Reports 2017; 2017: bcr-2016-218270
Abstract: A 49-year-old woman with cutaneous and uterine leiomyomas, flank pain and a family history of hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome sought genetic testing. She was found to harbour a fumarate hydratase (FH) genetic mutation and a previously undetected renal tumour. The patient underwent radical nephrectomy, and remains well at follow-up. HLRCC syndrome is a rare autosomal dominant disease, with patients at increased risk for cutaneous leiomyomas, early-onset uterine leiomyomas and aggressive renal carcinoma. Although the syndrome may manifest life-threatening complications, outcomes may be improved by preventative family screening and surveillance, compelling early diagnosis.
URI: https://ahro.austin.org.au/austinjspui/handle/1/19323
DOI: 10.1136/bcr-2016-218270
ORCID: 0000-0002-7833-2537
0000-0002-7372-0100
Journal: BMJ Case Reports
PubMed URL: 28122802
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.